DA approves 'robust' dementia drug that slows cognitive decline
After months of anticipation, US Food and Drug administration has finally granted traditional approval to lecemab, a drug that's been shown to significantly slow the progression of Alzheimer's.
Billy Dunn Teresa Buracchio Christophera Viehbacher Giovanni Frisoni Memory Centre Department Of Readaptation
Source: nypost.com